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 Emerging evidence has revealed that obesity and diets high in saturated 
fat are linked with pathophysiological changes in the dopaminergic reward 
system that disrupt satiety signals governing homeostatic food intake. Diets high 
in saturated fat are also implicated in the development of a metabolic syndrome-
like phenotype characterized by obesogenic weight gain, insulin resistance, and 
chronic inflammation. While there is evidence that anti-inflammatory unsaturated 
fats promote healthier metabolic profiles and brain health, little is known about 
the effects of diets high in unsaturated fat on dopamine neurotransmission which 
plays a role in feeding and satiety circuits. We sought to determine whether a diet 
high in unsaturated fat, in contrast to saturated fat, would prevent the 
development of a metabolic disorders and preserve normal dopamine function. 
To examine this, male C57BL/6 mice were fed, ad libitum, a low-fat (LF) control 
diet or a nutrient-matched diet high in either saturated fat (SFD) or unsaturated 
flaxseed oil (FSO) for six weeks. We measured food intake and body weight 
throughout the dietary intervention and after six weeks we assessed metabolic 
dysfunction with glucose tolerance tests and locomotor behaviors in an open field 
test. We subsequently measured sub-second dopamine release and uptake from 
dopamine neurons using ex-vivo Fast Scan Cyclic Voltammetry in the nucleus 
accumbens (NAc). Dopamine kinetics in response to the dopamine D2/D3 
receptor agonist quinpirole was also measured to assess dopamine receptor 
 
 
 
 
function. In order to assess the relationship between dietary fat, inflammation, 
and dopamine neurotransmission, the pro-inflammatory cytokine, interleukin-6 
(IL-6) was also measured in the NAc.  
Mice fed a SFD consumed significantly more food and gained significantly 
more weight compared to their LF-fed counterparts. In addition, unlike the LF 
group, the SFD group displayed anxiogenic locomotor behaviors in open field 
tests. Interestingly, the FSO group consumed the same amount of food as the 
SFD group; however, the FSO diet attenuated weight gain and preserved normal 
blood glucose regulation and locomotor behaviors. Significantly, the SFD group 
also exhibited dampened phasic dopamine release, impaired dopamine uptake 
and increased sensitivity to quinpirole, all of which was prevented with the FSO 
diet. There was also a negative association between dopamine uptake and IL-6 
in the SFD group suggesting IL-6 selectively corresponded with reduced 
dopamine uptake in mice fed saturated versus unsaturated fat. Collectively, we 
demonstrate that different types of dietary fat have substantially different effects 
on metabolic phenotype and dopamine terminal regulation. In contrast to a diet 
high in saturated fat, a diet high in unsaturated fat preserved both normal 
metabolic and behavioral parameters as well as dopamine signaling in the NAc.
 
 
 
 
THE EFFECT OF DIETARY FAT ON DOPAMINE 
NEUROTRANSMISSION 
 
by 
 
Cherie N. Barnes  
 
A Thesis Submitted to 
the Faculty of The Graduate School at 
The University of North Carolina at Greensboro 
in Partial Fulfillment 
of the Requirements for the Degree  
Master of Science 
 
 
Greensboro 
2019 
 
 
 
 
 Approved by 
 _____________________________ 
 Committee Chair
 
 
ii 
 
APPROVAL PAGE 
This thesis written by CHERIE N. BARNES has been approved by 
the following committee of the Faculty of The Graduate School at The University 
of North Carolina at Greensboro. 
 
 
 Committee Chair ___________________________ 
 
 Committee Members ___________________________ 
  ___________________________ 
 
 
 
 
 
 
___________________________ 
Date of Acceptance by Committee 
 
________________________ 
Date of Final Oral Examination  
 
 
iii 
 
ACKNOWLEDGEMENTS 
I want to thank my parents for all of their support. I am also very 
appreciative to members of my committee, Drs. Erickson and Armah, for their 
time, advice, and expertise. Most of all, I want to thank Dr. Fordahl for being a 
generous sponsor and an inspiring mentor. It has been an incredible privilege to 
work with you. 
  
 
 
iv 
 
TABLE OF CONTENTS 
Page 
LIST OF FIGURES ............................................................................................... vi 
CHAPTER 
I. REVIEW OF LITERATURE ....................................................................... 1 
Introduction ..................................................................................... 1 
Role of the Mesolimbic Dopamine System in  
Food-seeking Behaviors and Energy Homeostasis .................... 3 
Regulation of Dopamine Neurotransmission ................................... 5 
Impact of Diet and Obesity on Dopamine 
Dysregulation ............................................................................. 9 
Insulin Regulation of Mesolimbic Dopamine  
Neurotransmission ................................................................... 13 
Obesity, Saturated Fat and the Etiology of  
Insulin Resistance with Dopamine  
Neurotransmission ................................................................... 16 
Polyunsaturated Fatty Acids ......................................................... 20 
Conclusion .................................................................................... 21 
II. THE EFFECTS OF A HIGH SATURATED FAT DIET  
ON FOOD INTAKE, METABOLIC STATUS,  
AND LOCOMOTOR BEHAVIORS IN MICE ARE 
PREVENTED BY UNSATURATED FAT ............................................ 23 
Introduction ................................................................................... 23 
Methods ........................................................................................ 26 
Animals and Diet ...................................................................... 26 
Behavioral Testing ................................................................... 27 
Intraperitoneal Glucose Tolerance Test ................................... 28 
Statistical Analysis ................................................................... 28 
Results .......................................................................................... 29 
Food Intake Patterns and Body Weight ................................... 29 
Blood Glucose Regulation ....................................................... 30 
Locomotor Activity ................................................................... 32 
  
 
 
v 
 
Discussion ..................................................................................... 35 
High-fat Diet Promotes Increased Food 
Intake Leading to Obesogenic Weight Gain ........................ 35 
High-fat Diet Potentiates Metabolic  
Impairments ........................................................................ 36 
Anxiogenic Behavior Exhibited with  
Saturated Fat Diet ............................................................... 38 
Conclusion .................................................................................... 40 
III. IMPAIRED DOPAMINE NEUROTRANSMISSION IN  
THE NUCLEUS ACCUMBENS OF C57BL/6 MICE  
IS ASSOCIATED WITH SATURATED BUT 
NOT UNSATURATED FAT INTAKE .................................................. 41 
Introduction ................................................................................... 41 
Methods ........................................................................................ 45 
Animals and Diet ...................................................................... 45 
Fast Scan Cyclic Voltammetry ................................................. 46 
IL-6 Protein Quantification ....................................................... 48 
Statistical Analysis ................................................................... 49 
Results .......................................................................................... 49 
Effect of Dietary Fat on Dopamine  
Release and Uptake............................................................ 49 
Effect of Dietary Fat on D2 Autoreceptor  
Function in the NAc ............................................................. 52 
IL-6 Levels and Dopamine Neurotransmission ........................ 53 
Discussion ..................................................................................... 55 
Effect of Dietary Fat on Dopamine Release  
and Uptake .......................................................................... 55 
Effect of Dietary Fat on D2 Autoreceptor  
Function in the NAc ............................................................. 59 
IL-6 Levels and Dopamine Neurotransmission ........................ 61 
Conclusion .................................................................................... 63 
IV. EPILOGUE .............................................................................................. 65 
REFERENCES ................................................................................................... 69 
APPENDIX A. ANIMAL DIETS ........................................................................... 83 
  
 
 
vi 
 
LIST OF FIGURES 
Page 
Figure 2.1  Food Intake and Body Weight .......................................................... 30 
Figure 2.2  Blood Glucose Regulation ................................................................ 32 
Figure 2.3  Open-field Locomotor Activity ........................................................... 34 
Figure 3.1  Dopamine Release and Uptake ........................................................ 51 
Figure 3.2  Effect of Diet on D2 Autoreceptors ................................................... 53 
Figure 3.3  IL-6 Levels Related to Dopamine Neurotransmission....................... 55 
 
 
 
1 
 
CHAPTER I 
REVIEW OF LITERATURE  
Introduction 
Research related to diet-induced obesity has been traditionally viewed 
through the lens of a homeostatic model of food intake. This model is primarily 
focused on the ways that metabolic calorie requirements and the peripheral 
signaling molecules of hunger and satiety communicate with the central nervous 
system. The lateral hypothalamus, which is the “feeding center” of the brain, is 
central to energy homeostasis since it is the primary hub that receives peripheral, 
autonomic orexigenic and anorexigenic signals (Cassidy and Tong, 2017; 
Coccurello and Maccarrone, 2018). However, food-seeking and food intake 
behaviors take place within the larger context of all motivated behaviors and are 
therefore influenced by a rich interplay among multiple brain nuclei as well as 
peripheral signaling pathways. Within this larger context of motivated behaviors, 
the mesolimbic dopamine system plays a central role. It receives information 
related to all salient stimuli from numerous areas of the brain and peripheral 
endocrine system and subsequently integrates these signals to influence and 
modulate many functions including motor control, learning, cognitive function, 
motivation, mood, reward, addiction, and stress (Cassidy and Tong, 2017; 
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Coccurello and Maccarrone, 2018; Ferrario et al., 2016; Haber, 2011; Volkow et 
al., 2013, 2011). 
The mesolimbic dopamine signaling pathway is comprised of 
dopaminergic neurons originating in the ventral tegmental area (VTA) that project 
to the nucleus accumbens (NAc). This signaling pathway encodes and 
incentivizes salient rewards, thereby initiating motivated behaviors by actuating 
goal-directed movements (Salgado and Kaplitt, 2015). The NAc is of key 
importance since it is the limbic-motor interface as well as the primary reward 
center of the brain (Ferrario et al., 2016; Goto and Grace, 2008; Salgado and 
Kaplitt, 2015; Volkow et al., 2011). As such, the NAc is believed to underlie 
conditioning that links the memory of salient rewards that include both 
homeostatic and hedonic experiences with the context in which they occur and 
subsequently influence the desire and future pursuit of rewarding, salient 
reinforcers (Goto and Grace, 2008; Salgado and Kaplitt, 2015). Given the central 
role that the NAc plays in the motivational pursuit of reward and conditioned 
responses, it is implicated in the addictive effects of many illicit drugs of abuse 
(Volkow et al., 2013, 2003). More recently, it has been proposed that 
overconsumption of potent natural rewards, such as highly palatable foods that 
are high in sugar and fat, might also adversely affect VTA-NAc dopamine 
signaling. In extreme cases, it is possible that highly palatable foods cause 
synaptic alterations similar to drugs of abuse (Di Chiara and Bassareo, 2007; 
Volkow et al., 2013, 2011). This theory would explain pathological behavioral 
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patterns such as compulsive food seeking and consumption that exceed 
metabolic needs and therefore lead to obesity (Matikainen‐Ankney and Kravitz, 
2018). 
Role of the Mesolimbic Dopamine System in Food-seeking Behaviors and 
Energy Homeostasis 
 The mesolimbic dopamine system communicates with many nuclei in the 
CNS to modulate behaviors, motivators, and choices. Within the context of food 
seeking and food consumption behaviors, the VTA-NAc dopamine circuit assigns 
salience to external stimuli and directs motivated behavior based on both 
orexigenic and anorexigenic cues from the lateral hypothalamus and arcuate 
nucleus (Cassidy and Tong, 2017; Ferrario et al., 2016; Ferré, 2017). It also 
integrates these signals with excitatory inputs from the paraventricular thalamic 
nucleus related to arousal/motivation as well as executive function/decision 
making input from the prefrontal cortex (Arias-Carrión et al., 2010; Ferrario et al., 
2016; Ferré, 2017). Much like the lateral hypothalamus, the VTA and NAc also 
receive peripheral orexigenic and anorexigenic signals. For example, neurons of 
the VTA and NAc have receptors for classic autonomic energy homeostasis 
hormones/peptides such as GLP-1, leptin, ghrelin, orexin, insulin, and 
melanocortin (Ferrario et al., 2016). As both peripheral signals and central inputs 
are received, they are filtered and/or amplified based on their salience, leading to 
orchestrated, complex, goal-directed behaviors. Specific to feeding behaviors, 
the VTA-NAc is involved in food-related memory processing with the 
 
 
4 
 
hippocampus, emotional reactivity with the amygdala, food-cues for arousal with 
the thalamus, as well as higher-level executive decision-making related to food 
intake with the prefrontal and insular cortex (Ferrario et al., 2016; Goto and 
Grace, 2008). When these signals are in balance, salience associated with food 
is initiated by hunger cues and subsequently discontinued when adequate 
calories are consumed to support metabolic energy requirements. In the case of 
highly-palatable foods, hedonic hunger associated with mesolimbic dopamine 
can override homeostatic satiety cues, leading to overconsumption of food 
(Licholai et al., 2018). This phenomenon is significantly exacerbated when there 
are alterations in dopamine neurotransmission. For example, decreases in 
dopamine receptor activity can cause reductions in the elicited hedonic pleasure 
response associated with food and a resultant compensatory overconsumption of 
food (Ferrario et al., 2016; Kroemer and Small, 2016). In addition, since one of 
the downstream mesolimbic dopamine targets is the hypothalamic feeding 
center, reduced dopamine signaling also leads to a resultant decrease in 
inhibitory satiety cues that serve to discontinue food consumption (Ferrario et al., 
2016). In order to understand the underlying pathophysiology of alterations in 
dopamine neurotransmission, the following sections will discuss the mechanisms 
involved in dopamine neurotransmission as well as the effects of obesity and 
HFD on normal dopamine neurotransmission. 
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Regulation of Dopamine Neurotransmission 
Dopamine is a neurotransmitter that affects both the peripheral and central 
nervous system. Within the central nervous system, dopamine exerts potent 
effects due to the nature of dopamine neuron morphology, the unique dopamine 
transmission and receptor signaling mechanisms, as well as the specialized firing 
patterns of dopamine neurons (Cachope and Cheer, 2014; Goto and Grace, 
2008; Grace, 2000; Grace et al., 2007). 
The majority of dopamine neurons in the CNS reside in midbrain nuclei of 
the ventral tegmental area (VTA) and substantia nigra brain (Burke et al., 2017). 
These neurons have a unique morphology that features dense, diffuse axonal 
arborization (Cachope and Cheer, 2014; Goto and Grace, 2008; Grace, 2000; 
Grace et al., 2007). Dopamine neurons have been likened to oak trees where the 
branches of one neuron fills a large portion of their target regions (Arias-Carrión 
et al., 2010; Richard Palmiter, 2010). For example, a single dopamine neuron fills 
about 10% of the striatum, contacting tens of thousands of medium spiny 
neurons in the NAc, which are one of the predominant neuronal targets of 
dopamine signaling. The diffuse spread of these dopamine axons leads to a 
subsequent diffuse mode of dopamine transmission, or “volume transmission” 
(Cachope and Cheer, 2014; Richard Palmiter, 2010). Unlike synaptic, or “wired” 
neurotransmission that is ideal for high-speed and precise signaling, the 
temporally slower and diffuse nature of volume transmission is optimized for the 
modulation and fine-tuning functions of dopamine (Taber and Hurley, 2014). This 
 
 
6 
 
allows dopamine to act as a regulator, amplifier and reinforcer in response to 
salient stimuli (Arias-Carrión et al., 2010).  
Dopamine cell firing causes vesicular release of dopamine into the 
synaptic cleft via fusion with the pre-synaptic membrane. After dopamine is 
released, it subsequently binds to a family of G-coupled protein receptors located 
on target neurons. These dopamine receptors, which include classes D1-D5, are 
generally categorized as either low-binding-affinity D1-like receptors (D1, D5) or 
high-binding-affinity D2-like receptors (D2, D3, D4) (Beaulieu and Gainetdinov, 
2011). Medium spiny neurons (MSNs), which make up 95% of the neuron 
population of the NAc, can express both D1 and D2 receptors; however most 
express either D1-like receptors or D2-like receptors (Burke et al., 2017; Ford, 
2014; Scofield et al., 2016). In addition, there is a special population of D2-like 
autoreceptors (D2 and D3) that are expressed on dopamine neurons in the VTA. 
These autoreceptors provide inhibitory feedback control over pre-synaptic neuron 
activity by regulating tonic dopamine levels, DAT activity, dopamine synthesis, as 
well as the frequency and amplitude of phasic dopamine release (Cachope and 
Cheer, 2014; Ford, 2014; Siciliano et al., 2015a; Sulzer et al., 2016).  
Since there is a pattern of preferential expression of either D1-like 
receptors or D2-like receptors of MSN’s within the NAc, it is interesting to note 
that there are functional distinctions between D1 and D2 receptors that emerge 
when one examines their different roles in response to the two different types of 
firing activity exhibited by dopamine neurons. Dopamine neurons fire regularly at 
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tonic, slow, pacemaker-like frequencies (2−10 Hz). In addition, they also fire in 
phasic bursts (~20 Hz). Tonic firing results in the release of small amounts of 
dopamine that primarily bind high-affinity, inhibitory, D2-like receptors (Arias-
Carrión et al., 2010; Ford, 2014). Therefore, it is believed that tonic release 
largely serves a feedback role. In contrast, phasic firing is exemplified by rapid, 
discreet, high-frequency spike activity of 2-6 action potentials that are ≥ 20 Hz 
(Goto and Grace, 2008; Siciliano et al., 2015a; Sulzer et al., 2016; Wenzel et al., 
2015). Phasic burst-firing, which occurs in response to biologically salient stimuli, 
such as unexpected rewards, reward cues, or anticipated receipt of a known 
reward (e.g. palatable food), leads to the release of large concentrations of 
dopamine that are sufficient to saturate high-affinity D2 receptors and also 
activate low-affinity D1 receptors. This high concentration is also sufficient to 
elicit the dopamine transporter (DAT) activity of dopamine neurons. The DAT 
serves several critical functions: 1) it quickly removes dopamine from the 
synaptic space to shape and ultimately terminate phasic signaling events 2) it 
provides a mechanism for recycling of dopamine for use in subsequent release 
3) it also plays a role in regulating tonic extracellular dopamine levels (Cachope 
and Cheer, 2014; Rice and Patel, 2015; Siciliano et al., 2015a; Sulzer et al., 
2016). 
Both tonic and phasic firing are involved in the execution of motivated 
behaviors, but they have different roles in this respect. Interestingly, increased 
tonic dopamine is associated with enhanced reward seeking since it primes the 
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dopamine signaling system and therefore elicits increased phasic signaling 
responses to future stimuli (Beeler and Mourra, 2018; Siciliano et al., 2015a). 
However, since tonic dopamine primarily activates D2 receptors while phasic 
release activates both D1 and D2 receptors, it is interesting to compare the 
effects of activating low-affinity D1 versus high-affinity D2 receptors. The distinct 
qualities of D1 and D2 receptors related to binding affinity and target receptor 
effects suggests that they play complementary roles in the downstream effects of 
dopamine. MSN’s in the NAc that predominantly have D2 receptors indirectly 
project to the ventral mesencephalon via the ventral pallidum and cause reduced 
motivation, motor output and goal-directed behavior (Arias-Carrión et al., 2010). 
In contrast, D1 receptor activity is associated with reinforcing reward and 
promotion of reward-conditioned place preference (Calipari et al., 2016; Lobo et 
al., 2010; Scofield et al., 2016).  
Since mesolimbic dopamine neurotransmission governs reward and goal-
seeking behaviors, alterations in dopamine neurotransmission can lead to 
behavioral changes in food seeking and food intake. For example, the opposing 
roles of D1 and D2 receptors specifically related to food consumption have been 
demonstrated in a rodent model by Ball and colleagues. When rats were given a 
D1-like antagonist it completely blocked discrete cue-induced reinstatement of 
food seeking. In contrast, administration of D2-like antagonist significantly 
increased reinstatement responding that elicited cue-induced relapse to food 
seeking (Ball et al., 2011). A reduction in D2 autoreceptors, which serve an 
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important feedback role for dopamine release, also affect food seeking and 
intake behaviors. This was elegantly demonstrated in a novel cre/lox mouse 
model by Bello and colleagues. They reported that mice lacking D2 
autoreceptors (autoDrd2 KO) had elevated dopamine synthesis/release, 
hyperlocomotion, elevated sensitivity to the psychomotor effects of cocaine, as 
well as enhanced motivation for food reward (Bello et al., 2011). Changes in DAT 
also have a profound effect on eating behaviors. The consequences of reduced 
DAT activity are exemplified by a study using DAT-knockdown mice. Compared 
to wild-type control, DAT-deficient mice have increased levels of extracellular 
dopamine and exhibit significantly greater food intake compared to control wild-
type mice (Peciña et al., 2003). In humans, similar evidence showed that 
polymorphisms in the DAT gene associated with decreased DAT activity and 
DAT expression increased susceptibility to binge eating behaviors (Fuke et al., 
2001; Heinz et al., 2000; Shinohara et al., 2004). 
The above evidence demonstrates that altered dopamine 
neurotransmission can lead to behavioral changes in eating behaviors. 
Conversely, dietary factors and diet-induced obesity can lead to changes in 
dopamine neurotransmission.  
Impact of Diet and Obesity on Dopamine Dysregulation 
It is well-established that highly-palatable foods, which are high in fat and 
sugar, exert strong effects on the dopaminergic reward system (Ferrario et al., 
2016; Matikainen‐Ankney and Kravitz, 2018). Addiction research classically 
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employs food reward models since drugs of abuse also exert their effects on the 
dopaminergic reward system. (Di Chiara and Bassareo, 2007; Volkow et al., 
2013, 2011). Drug addiction models are associated with changes in the 
expression and activity of the regulatory feedback for dopamine 
neurotransmission which cause pathological behavioral selection and anhedonia 
resulting in enhanced seeking/consumption of rewards (Coccurello and 
Maccarrone, 2018; Di Chiara and Bassareo, 2007; Scofield et al., 2016; Volkow 
et al., 2013, 2011). There is currently a debate about whether to classify chronic 
overconsumption of food related to obesity as a “food addiction”. However, 
addiction research has elucidated that pathological changes in dopamine 
neurotransmission observed in addiction models related to reduced numbers of 
functional DAT and dopamine receptors are also associated with obesity and 
high fat diets (Baik, 2013a; Cone et al., 2013; Fordahl et al., 2016; 
Narayanaswami et al., 2013).  
One specific similarity between drug addiction models and obesity/HFD is 
related to D2 receptors. There is a large body of research demonstrating that 
many drugs of abuse have addictive effects due to resultant decreases in D2 
receptor expression and activity. There is also evidence that obesity and HFD 
also decrease D2 receptor activity. Imaging studies have shown that D2 receptor 
expression is significantly decreased in obese subjects in inverse relationship to 
their body mass index (Volkow et al., 2003; Wang et al., 2001). Similar results 
were demonstrated in two studies that reported a negative association between 
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striatal D2 and D3 receptor function with increased BMI (de Weijer et al., 2011; 
Kessler et al., 2014; Matikainen‐Ankney and Kravitz, 2018). In addition, multiple 
studies of HFD-induced obesity in rodents have demonstrated that overweight 
and obese rodents on HFD had significantly reduced expression of D2R as well 
as decreased D2R binding compared to control (Hajnal et al., 2008; Huang et al., 
2006; Matikainen‐Ankney and Kravitz, 2018). Decreased post-synaptic D2 
receptors results in a dampened response to salient stimuli and potentially 
increase vulnerability to substance abuse since D2 receptors in the NAc provide 
inhibitory feedback to the VTA (Dobbs et al., 2017). Studies performed by the 
France lab using dopamine receptor agonists also support the evidence above. 
Rats who were fed a HFD were more sensitive to the D2/3 receptor agonist, 
quinpirole, compared to control. The HFD rats had increased sensitivity to 
quinpirole-induced discriminative stimulus effects and exhibited increased 
yawning (a behavioral effect of quinpirole) (Baladi et al., 2011; Baladi and 
France, 2010; Serafine and France, 2013).  
Another key commonality observed between drug addiction and HFD-
induced obesity models is decreased dopamine re-uptake by the DAT (Baik, 
2013a; Cone et al., 2013; Fordahl et al., 2016; Narayanaswami et al., 2013). This 
is important since DAT uptake of dopamine is the primary mechanism for 
terminating phasic signaling in response to salient stimuli. The effect of reduced 
DAT function is delayed termination of phasic burst firing, enhanced tonic 
signaling, and an overall increase in synaptic dopamine (Sulzer et al., 2016). 
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Over time, elevated synaptic dopamine leads to a compensatory reduction in 
post-synaptic dopamine receptors and increased consumption of salient rewards 
(Blum et al., 2014; Koob, 2013; Narayanaswami et al., 2013). Additionally, 
decreased DAT function and the resultant high levels of extra-synaptic dopamine 
results in feedback mechanisms via pre-synaptic D2 autoreceptors. This is 
significant since the binding of dopamine to pre-synaptic D2 autoreceptors 
subsequently reduce excitability of dopamine neurons and also reduce synthesis 
and release of dopamine (Ford, 2014).  
Decreased DAT activity observed with HFD-induced obesity is primarily 
due to decreased trafficking of the DAT to the pre-synaptic membrane. This is 
supported by a study in HFD-obese rodents where DAT mRNA and DAT protein 
are not globally affected however, the DAT was localized in cytosolic endosomes 
rather than the plasma membrane where they are functionally active (Cone et al., 
2013). The functional effects of decreased levels of membrane DAT have been 
reported in studies of HFD-induced obesity where dopamine uptake, measured 
using voltammetry, was significantly reduced in rodents fed a diet high in fat 
compared to control (Cone et al., 2013; Fordahl et al., 2016). 
The underlying explanation for the role of obesity/HFD in dopamine 
neuroplasticity that contributes to dysregulated food seeking and food intake 
behaviors are likely multifactorial. In addition to dopaminergic adaptations, 
plasticity changes in glutamatergic neurons that act on dopamine neurons in the 
NAc may also occur with a HFD, resulting in increased dopamine release 
 
 
13 
 
(Ferrario et al., 2016). Over time the increased release of dopamine leads to an 
adaptive decline in dopamine receptor availability via compensatory down-
regulation mechanisms. While the above evidence of the effect of HFD/obesity 
on dopamine release and re-uptake demonstrates that it is implicated in 
dysregulated dopamine neurotransmission the underlying causes of these 
adaptive declines are not fully understood. However, insulin putatively plays a 
central role since it is involved in the regulation of mesolimbic dopamine release 
by acting in the VTA as well as dopamine clearance in the NAc (Ferrario et al., 
2016). In addition, insulin’s influence on the mesolimbic dopamine system are 
underscored by the fact that the mesolimbic dopamine system has a dense 
population of insulin receptors (Schulingkamp et al., 2000; Sulzer et al., 2016). In 
addition, diets high in saturated fat and obesity are associated with insulin 
resistance. Given insulin’s role in dopamine neurotransmission, recent research 
findings related to the roles of insulin and the potential effects of insulin 
resistance merit a detailed discussion.  
Insulin Regulation of Mesolimbic Dopamine Neurotransmission 
Insulin is classically regarded as an anabolic hormone that is primarily 
involved with energy homeostasis and blood glucose regulation. However, it is 
now understood that insulin can cross the blood brain barrier and work in concert 
with the mesolimbic dopamine system to modulate goal-directed behaviors 
associated with food-seeking and food intake (Banks, 2004; Daws et al., 2011; 
Stouffer et al., 2015).  
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Compelling evidence of insulin’s effects on dopamine signaling have been 
demonstrated in several human studies that used intranasal insulin (INI) 
administration. Kullmann and colleagues reported that INI led to decreased food 
consumption and attention to food-related cues (Kullmann et al., 2015, 2013). 
Similarly, Tiedemann and colleagues studied the effect of INI versus placebo on 
fasted subjects who were presented with images of highly-palatable food. 
Pharmacological fMRI revealed that INI reduced food palatability ratings as well 
as reduced “value” signaling in mesolimbic regions in subjects with normal insulin 
sensitivity. In addition, insulin inhibition mechanisms affected forward projections 
from the VTA to the NAc. Importantly, these effects were not observed in 
subjects receiving INI who were insulin resistant. (Tiedemann et al., 2017).  
The effect of insulin on dopamine neurons have also been demonstrated 
in rodent models. The specific behavioral effects of insulin reported in rodent 
models include reduced food anticipatory behavior, decreased place-preference 
related to highly palatable food, and reduced hedonic feeding (Ferrario et al., 
2016; Figlewicz et al., 2006, 2004; Labouèbe et al., 2013; S. Liu et al., 2013; 
Mebel et al., 2012; Patel et al., 2018). Closer examination of the mechanistic 
effects of insulin demonstrate that it has pleiotropic effects on dopamine neurons. 
The Borgland lab reported that insulin acts on dopamine neurons in the VTA by 
suppressing excitatory synaptic transmission (Labouèbe et al., 2013; Liu et al., 
2016; Mebel et al., 2012).  
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Many of the effects of insulin are initiated when it binds to insulin receptors 
on dopamine neurons that in turn activate the PI3K/Akt signaling cascade. Once 
phosphoinositide 3-kinases (PI3K) are activated they initiate a classic signaling 
cascade by phosphorylating the D-3 position of phosphoinositides to generate 
PI(3,4,5) P3(PIP3), which then phosphorylates/activates protein kinase B (Akt) by 
acting at the plasma membrane as a second messenger (Daws et al., 2011). The 
PI3K/Akt signaling cascade is significant because it enhances surface expression 
of DAT. The Akt/DAT link has been demonstrated by several research groups, 
where inhibition of PI3K and Akt resulted in reduced dopamine clearance and 
surface expression of the DAT (Carvelli et al., 2002; Daws et al., 2011; Garcia et 
al., 2005). Doolen and colleagues used a different model to investigate insulin’s 
effect on DAT trafficking. They reported reduced synaptic dopamine clearance 
due to decreased DAT protein levels at the plasma membrane in cells treated 
with tyrosine kinase inhibitors which block insulin-activated receptors (Daws et 
al., 2011; Doolen and Zahniser, 2001). The effects of insulin on DAT activity is 
further supported by studies using fast scan cyclic voltammetry (FSCV). In these 
studies, direct application of insulin on ex-vivo brain slices containing the NAc 
significantly increased dopamine uptake (Fordahl et al., 2016; Patel et al., 2018; 
Stouffer et al., 2015). The evidence of these effects are further supported when 
the underlying mechanisms were investigated using DAT-expressing embryonic 
cells which exhibited significantly increased dopamine uptake when insulin was 
applied to the tissue cultures (Carvelli et al., 2002). 
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Given the effects of insulin on dopamine neurotransmission, it has been 
proposed that insulin resistant states could contribute to the adaptive decline in 
dopamine neurotransmission observed with the development of obesity and 
metabolic syndrome.  
Obesity, Saturated Fat and the Etiology of Insulin Resistance with 
Dopamine Neurotransmission 
Changes in dopamine neurotransmission related to obesity/HFD 
compared with the effects of insulin on dopamine neurotransmission are striking 
since obesity/HFD and insulin have several significant opposing effects related to 
regulation of DAT and dopamine receptors. This suggests that that obesity and 
HFD may affect dopamine neurotransmission by causing insulin resistance and 
thereby impairing the effectiveness of insulin to act on dopamine neurons. The 
link between HFD and insulin-related dysregulation of dopamine 
neurotransmission is supported by two key lines of evidence: 1) There is a 
growing body of research that demonstrates an association between insulin 
resistance/diet-induced obesity with dysregulated dopamine neurotransmission 
2) It is well-established that obesity and diets high in saturated fat are associated 
with peripheral insulin resistance. 
Repeated exposure to a HFD has been mechanistically linked to 
impairment of insulin signaling (i.e., insulin-activated signaling kinase), decrease 
of DAT cell expression and activity, dopamine clearance and amphetamine-
mediated effects (Speed et al., 2011). In addition, the association between 
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obesity and HFD on insulin’s effect on dopamine neurotransmission have been 
demonstrated in hypoinsulinemic and streptozotocin-induced (STZ) diabetic 
rodent models. Hypoinsulinemic rats had a significantly decreased maximal 
velocity (Vmax) for dopamine uptake compared to control (Daws et al., 2011; 
Patterson et al., 1998). Similarly, STZ rats had significantly decreased trafficking 
and activity of DAT evidenced by decreased in dopamine uptake (Daws et al., 
2011; Owens et al., 2012, 2005; Williams et al., 2007). The France lab 
corroborated the above results using dopamine receptor agonists. They reported 
that, compared to a chow control, rats on a HFD had increased sensitivity to 
quinpirole and a parallel decreased insulin sensitivity (Baladi et al., 2011). 
Evidence of the link between insulin resistance and altered dopamine 
neurotransmission have also been observed in human imaging research by 
Caravaggio and colleagues. Their study used PET scans in combination with 
radiotracers specific to D2/3 receptors and alpha-methyl-para-tyrosine-induced 
dopamine depletion. They reported that there was a positive association between 
insulin sensitivity and ventral striatal levels of D2/3R (Caravaggio et al., 2015). 
The mechanistic explanation related to obesity/HFD and insulin’s 
regulation of dopamine neurotransmission is not well understood. However, it 
has been proposed that inflammation plays a role given the well-established 
effects of obesity and HFD in promoting systemic inflammation and subsequent 
insulin resistance. 
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Regarding the effect of fat storage in peripheral tissues, it is well 
established that obesity induces insulin resistance due to its role in low-grade 
systemic inflammation (Chen et al., 2015; Rehman and Akash, 2016). Obesity-
related inflammation mechanisms are a result of adipokine production and 
immune cell stimulation. Fat accumulation patterns observed with obesity are 
primarily due to excess accumulation of biologically active white adipose tissue 
(WAT). WAT releases pro-inflammatory adipokines including TNF-α, interleukin 
(IL)-6, and IL-1β. In addition, regions of WAT secrete chemo-attractants such as 
MCP-1 and MIF that recruit local immune cell populations that express pro-
inflammatory M1 macrophages that are present in excess compared to their M2, 
anti-inflammatory macrophage counterparts. The inflammation due to pro-
inflammatory adipokines and activity of the pro-inflammatory M1 macrophages 
induce insulin resistance by activating serine kinases such as IκB kinase (IKK) 
and JNK. IKK and JNK kinases directly induce insulin resistance by 
phosphorylating/inactivating insulin receptor substrate-1 (IRS-1). This directly 
counters insulin’s ability to induce tyrosine phosphorylation of IRS-1 (McArdle et 
al., 2013). 
In addition to inflammatory adipose tissue, diets that are specifically high 
in saturated fatty acids (SFA) also promote inflammation-induced insulin 
resistance since SFAs are precursor components of pro-inflammatory signaling 
pathways. These include the following: 1) SFA is a precursor of diacylglycerols 
(DAG) that affect PKC activation (Kumashiro et al., 2011); 2) SFAs are also 
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precursors to ceramides. Ceramides are an inflammatory class of sphingolipids 
that induce insulin resistance by inhibiting Akt/PKB signaling through two 
independent pathways. Ceramides catalyze the dephosphorylation of Akt/PKB by 
activating protein phosphatase 2A and block Akt/ PKB translocation to the 
plasma membrane (Glass and Olefsky, 2012; Holland et al., 2007). 3) SFAs also 
stimulate NADPH oxidase production of reactive oxygen species (ROS) that in 
turn act on ‘‘lipid rafts’’ domains in macrophages and lead to stimulation of 
inflammation via JNK1 (Rogero and Calder, 2018; Verdile et al., 2015). 4) Finally, 
one of the best studied roles of SFAs is their ability to induce the release of pro-
inflammatory cytokines such as TNF-α, interleukin (IL)-6, and IL-1β by causing 
the dimerization of the toll-like receptors, Tlr2 and Tlr4 (Rogero and Calder, 
2018).  
Based on the large body of evidence related to the effect of saturated fat 
on inflammation in peripheral tissues, there has been increased interest in 
understanding the effect of SFA in inflammation in the CNS. Preliminary studies 
suggest that SFAs exert pro-inflammatory effects on the CNS by activating 
immune response. Dietary SFA has been associated with increased production 
of pro-inflammatory cytokines related to microgliosis and insulin resistance (Erta 
et al., 2012; Jais and Brüning, 2017; Shih et al., 2015). While this preliminary 
evidence suggests that SFA is implicated in neuroinflammation, more 
investigation is needed to understand the full impact of dietary fat on 
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inflammation in the CNS and its resultant effects on neurotransmission and brain 
health. 
Polyunsaturated Fatty Acids 
In contrast to the role that SFAs play in inflammation and insulin 
resistance, omega-3 polyunsaturated fatty acids (PUFA) exert opposing effects 
that reduce inflammation and promote insulin sensitivity. Several large human 
studies have demonstrated an association between increased dietary PUFA and 
improved insulin sensitivity. Several key observational studies have also reported 
an inverse association between circulating PUFA levels and the index of insulin 
resistance (Lalia and Lanza, 2016). PUFAs exert their influence on inflammation 
and insulin sensitivity via numerous anti-inflammatory/regulatory mechanisms. 
These include anti-inflammatory effects that are not currently linked to SFA-
induced insulin resistance that are outside the scope of this review.  
The ability of PUFA to antagonize the actions of SFA-induced insulin 
resistance has been well documented in numerous animal studies where SFA-
induced insulin resistance in both mice and rat studies was attenuated with 
PUFA supplementation. (Kalupahana et al., 2010; Lalia and Lanza, 2016; Lionetti 
et al., 2014; X. Liu et al., 2013). The ability of PUFAs to attenuate insulin 
resistance are mechanistically explained by studies that examined the 
association between PUFA and insulin signaling pathways in peripheral tissues. 
In these studies, SFA-induced insulin resistance models demonstrated that 
PUFA increased mRNA expression of insulin receptor (IR) and insulin receptor 
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substrate-1 (IRS1), both of which promote insulin signaling through increased 
activation of IR/IRS1 phosphorylation and subsequent PI3K activity (Lalia and 
Lanza, 2016).  
Pre-clinical cell and animal models provide evidence to explain the 
underlying mechanistic effects of PUFA on insulin signaling and inflammation. 
The effects of PUFA on insulin signaling pathways have been attributed in part to 
PUFA’s well-established antagonism of classic pro-inflammatory TLR-associated 
cytokines, thereby reducing production of TNF-α, IL-6, and IL-1B (Calder, 2015). 
Some of the mechanistic effects of PUFAs on these cytokines include: 1) 
Activation of the transcription factor, peroxisome proliferator activated receptor 
gamma (PPAR-γ), which physically inhibits the translocation of NFκB to the cell 
nucleus (Rogero and Calder, 2018), 2) Inhibition of the cell-membrane lipid raft 
signaling between TLR4 and myeloid differentiation primary response gene 88 
(MyD88) (Calder, 2015), 3) Activation of the G-protein-coupled receptor 120 
(GPR 120) which inhibits both TLR and subsequent downstream TNF-α 
inflammatory signaling pathways by reducing activation of the NFκB signaling 
pathway (Calder, 2015; Lalia and Lanza, 2016; Oh et al., 2010). 
Conclusion 
It is important to understand how diets high in SFA cause dysregulated 
dopamine signaling in the NAc since it would elucidate the underlying causes of 
diet-induced obesity associated with excessive/compulsive food seeking and 
consumption that exceed metabolic needs. The above sections have presented 
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evidence that 1) Diets high in SFA can cause inflammation, insulin resistance 
and dysregulated dopamine neurotransmission, 2) Insulin resistance has adverse 
effects within the mesolimbic dopamine pathway since insulin fine tunes 
dopamine neurotransmission to reduce food seeking and support meal 
termination, and 3) Unsaturated fat exerts anti-inflammatory effects that oppose 
the effects of SFA and improve insulin sensitivity. Despite the overlapping 
associations described above, there is a paucity of research establishing 
definitive links related to the inflammatory effects of different dietary fats on the 
insulin sensitivity of neurons in the VTA-NAc dopamine mesolimbic pathway 
even though it has one of the densest population of insulin receptors in the CNS 
(Schulingkamp et al., 2000; Sulzer et al., 2016). For these reasons, addressing 
research gaps related to effects of dietary fat on inflammation associated with 
dopamine neurotransmission are warranted. Since diets high in unsaturated fats 
promote brain health and improve insulin signaling putatively though attenuated 
inflammation, the anti-inflammatory properties of unsaturated fats, these 
“healthier” fats may preserve dopamine signaling and prevent adaptations at 
dopamine terminals in the NAc that contribute to hedonic food intake.
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CHAPTER II 
THE EFFECTS OF A HIGH SATURATED FAT DIET ON FOOD INTAKE, 
METABOLIC STATUS, AND LOCOMOTOR BEHAVIORS IN MICE ARE 
PREVENTED BY UNSATURATED FAT 
Introduction 
There is a growing body of evidence that implicates diets high in saturated 
fat with increased risk for the development of metabolic syndrome in humans 
(Chen et al., 2015; Nettleton et al., 2014; Rehman and Akash, 2016). Similarly, 
rodent studies investigating the effects of dietary fat report the development of 
metabolic syndrome-like phenotypes characterized by obesogenic weight gain, 
insulin resistance, and chronic inflammation after consuming high amounts of 
saturated fat (Décarie-Spain et al., 2018; Jais and Brüning, 2017; Rogero and 
Calder, 2018). In addition, rodent studies suggest that normal, homeostatic food 
intake and locomotor behaviors are also disrupted by high saturated fat feeding 
(Décarie-Spain et al., 2018; Fordahl et al., 2016; Hryhorczuk et al., 2016; Speed 
et al., 2011). While a diet high in saturated fat is directly linked to metabolic 
pathophysiology, weight gain, and behavioral changes, it is not known whether 
unsaturated fats can attenuate or prevent the metabolic and behavioral effects 
observed with a high saturated fat diet.
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The most significant effects of a high fat (HF) diet leading to excessive 
food intake are observed when rodents have free access to a HF diet 
(Hryhorczuk et al., 2016; Jones et al., 2017; Licholai et al., 2018; Yang et al., 
2014). Compared to intermittent access to HF food, mice specifically provided an 
ad libitum diet high in saturated fat consumed food well beyond their metabolic 
calorie needs. This is interesting since it suggests that hedonic hunger may be 
the primary contributor to overconsumption of a HF diet (Licholai et al., 2018). 
Since hedonic food intake is regulated by the nucleus accumbens (NAc), it is 
possible that a HF diet specifically causes plasticity changes in the NAc that lead 
to hedonic reward that overrides homeostatic satiety cues (Arias-Carrión et al., 
2010; Berridge, 2009). This is supported by a study examining the effects of 
cocaine, which directly affects dopamine signaling in the NAc of HF-fed rats 
(Serafine et al., 2016). Rats fed a HF diet gained significantly more weight than 
LF controls, developed metabolic dysfunction, and exhibited increased sensitivity 
to cocaine-induced locomotion. Another study that compared HF to LF reported 
anxiodepressive behaviors and increased motivation to consume sucrose in HF-
fed mice with metabolic dysfunction. Interestingly, viral inhibition of the 
inflammatory IKKb/NFkB pathway in the NAc prevented diet-induced 
anxiodepressive behavior and neuroinflammation caused by the HF diet 
(Décarie-Spain et al., 2018). In addition to the anxiodepressive phenotype, HF 
diets are implicated in numerous neural adaptations that lead to escalating intake 
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of food, compulsive behaviors, and anhedonia (Pandit et al., 2012; Sharma and 
Fulton, 2013).  
It is important to emphasize that the well-established metabolic syndrome-
like phenotype described above is produced by diets that are specifically high in 
saturated fat. However, it is not known whether different types of fat have the 
same effect. This is an essential question to address since saturated fat is 
specifically associated with pro-inflammatory states while mono- and 
polyunsaturated fats have anti-inflammatory effects that are associated with 
healthy metabolic profiles (Calder, 2015). Indeed, emerging evidence suggests 
that there are important differences. It has been consistently demonstrated that 
rodents provided diets high in mono- and polyunsaturated fats do not develop the 
obesity, insulin resistance, or systemic inflammation observed in rodents fed 
diets high in saturated fat. In recent studies, these metabolic differences were 
also accompanied by changes in behaviors such as reduced sensitivity to 
cocaine and amphetamine as well as reduced anxiodepressive and compulsive 
sucrose-seeking behaviors (Décarie-Spain et al., 2018; Fordahl et al., 2016; 
Serafine et al., 2016). Interestingly, the diet-induced inflammation and 
neuroplastic changes in the NAc observed with a diet high in saturated fat were 
ameliorated when unsaturated fat was directly infused into neurons that project to 
the NAc (Hryhorczuk et al., 2018). In addition, unsaturated fat decreased food 
intake, increased locomotor activity, and attenuated the rewarding-seeking 
behaviors to attain highly-palatable food.  
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Since high saturated fat diets and a resultant metabolic syndrome-like 
phenotype impact locomotor activity and behavioral responses to drugs that act 
on dopamine signaling while unsaturated fats attenuate responses to dopamine 
agonists and dopamine neuron activity, we examined whether a diet high in 
unsaturated fats had similar effects on overall locomotor behaviors. We also 
examined whether differences in metabolic phenotype between high saturated 
vs. high unsaturated fats contributed to these effects. In order to verify that our 
model replicates the metabolic syndrome-like phenotype reported in previous 
studies, we provided mice with a high saturated fat diet and measured: 1) food 
intake; 2) weight gain; 3) glucose clearance as a proxy for metabolic dysfunction; 
and 4) locomotor behaviors in an open field test. Matching groups of mice were 
fed HF diets containing unsaturated flaxseed oil to test whether unsaturated fat 
prevents the development of metabolic and behavioral disorders commonly 
associated with obesity and diets high in saturated fat. We hypothesized that 
unsaturated fat would attenuate or prevent weight gain, improve blood glucose 
regulation, and attenuate changes in locomotive behaviors observed with a diet 
high in saturated fat. 
Methods 
Animals and Diet  
Six-week-old male C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) and were housed three per cage, maintained on a 
12 h light/dark cycle with access to water and fed an ad libidum low-fat control 
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diet (LF; 10% kcals from fat; D12450J, Research Diets, n=6) or one of three 
nutrient matched experimental diets containing 60% kcals from either saturated 
fat (SFD) (D12492, Research Diets, n=9), saturated fat combined with flaxseed 
oil (Blend) (1:1 ratio of saturated fats to n3 polyunsaturated fats) (Prelim Form 2, 
Research Diets, n=6) or flaxseed oil alone (FSO) (Prelim Form 1, Research 
Diets, n=6). Custom flax diets were similarly nutrient matched to both high and 
low-fat diets, and calorically matched to the high saturated fat diet (Appendix; 
Table I). Food intake was measured on M/W/F by weighing the amount of diet 
consumed and calculating caloric intake based on food disappearance, and 
averaging intake by the number of mice in each cage. Body weights were 
measured upon arrival and weekly thereafter. Mice remained on respective diets 
for 6 weeks prior to experimental tests. All experiments were in compliance with 
the University of North Carolina at Greensboro Animal Care and Use Committee.  
Behavioral Testing 
Locomotor activity was assessed using an open field test. Behavioral 
experiments were initiated during the first four hours of the light cycle and were 
conducted using plexiglass chambers (30 cm × 30 cm × 60 cm). The chambers 
were sanitized prior to each experiment and the walls of the plexiglass chambers 
were wrapped in white coating with white disposable white floor linings to reduce 
external stimuli variability. Mice were removed from their home cages, 
immediately placed in the center of the arena and allowed to explore freely for 
10 minutes. The total distance traveled (mm) and number of bouts entering the 
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center were measured using TopScanLite (Version 2.0, CleverSys Inc) for the 
first 10 minutes after being placed in the arena. The defined center area (45% of 
perimeter area) and length of time used for behavioral analysis were derived 
from standard reported practices for open field behavioral testing (Seibenhener 
and Wooten, 2015).  
Intraperitoneal Glucose Tolerance Test 
At the end of the 6-week dietary protocol, all mice underwent an 
intraperitoneal glucose tolerance test (IPGTT) to measure glucose clearance as 
proxy for metabolic dysfunction. Briefly, mice were placed in clean cages two 
hours into the dark cycle with access to water, but no food, for a 9 h fast. Blood 
glucose levels were then measured from the tail vein using a TRUEtrack 
glucometer and blood glucose test strips (Rite Aid Pharmacy, Camp Hill, PA) to 
establish fasting blood glucose levels. An i.p. bolus of glucose (2 g/kg in 20% w/v 
saline) was delivered and repeat blood glucose measurements were 
subsequently performed at 15, 30, 60, and 120 min thereafter.  
Statistical Analysis  
Graph Pad Prism v.5 (La Jolla, CA) was used for all statistical analyses. 
Two-way repeated measures analysis of variance (ANOVA) was used to identify 
significant differences within and between treatment groups for body weight and 
IPGTT using Tukey’s posthoc analysis to identify significant variations between 
groups at individual data points, when applicable. One-way ANOVA tests were 
used to analyze between group differences for food intake, fasting blood glucose, 
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area under the curve data for IPGTT, and locomotor activity measurements. 
Pearson’s correlational analysis was used to identify relationships between 
distance travelled x body weight and center entries x body weight. Group data 
are presented as means ± SEM; statistical significance was set at p ≤ 0.05. 
Results 
Food Intake Patterns and Body Weight  
Mice in the SFD, Blend and FSO groups consumed significantly more 
calories (kcals) per day than the LF group (13.9 ± 0.18 g/d, 14.1 ± 0.39 g/d, 
13.5 ± 0.31 g/d, and 10.0 ± 0.18 g/d respectively; p < 0.0001). There was no 
significant difference of caloric intake between the SFD, Blend and FSO groups 
(Figure 2.1A). At the end of the 6-week diet intervention the final body weight of 
the FSO group (32.6 ± 1.1 g) was significantly greater than the LF group 
(25.8 ± 0.9 g) (p < 0.0001), but significantly less than the SFD group 
(37.7 ± 0.9 g) (p < 0.001). The final body weights in the SFD and Blend 
(36.9 ± 1.3 g) groups were similar (Figure 2.1B), and the Blend group was 
significantly greater than the LF and FSO groups (p < 0.0001 and p = 0.0042 
respectively). Therefore, even though there was no statistically significant 
difference in caloric intake between the SFD, Blend and FSO groups, the 
FSO group did not gain as much weight on average as either the SFD group or 
Blend groups (p < 0.001). However, the FSO group weighed significantly more 
than the LF group (p < 0.0001). A two-way ANOVA identified a significant effect 
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of dietary treatment on body weight (F(3, 23) = 20.7; p < 0.0001) (Figure 2.1B), 
indicating that dietary fat amount, and importantly fat type, both impacted body
weight. 
Blood Glucose Regulation  
To examine the metabolic impact of SFD and unsaturated FSO, we 
measured fasting blood glucose and blood glucose clearance with IPGTT. 
Fasting blood glucose was not significantly different between the LF (118.3 ± 6.7 
mg/dl) and FSO (109.7 ± 10.8 mg/dl) groups (p = 0.9637) (Figure 2.2A). In 
contrast, fasting blood glucose was significantly elevated in the SFD group 
(184.9 ± 13.1 mg/dl) compared to the LF (118.3 ± 6.7 mg/dl) and FSO (109.7 ± 
10.8 mg/dl) groups (p = 0.0029 and p = 0.0008, respectively). The fasting blood 
Figure 2.1 Food Intake and Body Weight 
(A) Mice fed SFD (n=9), FSO (n=6), and Blend (n=6) diets consumed a similar amount of kilocalories
(kcals), which was significantly greater than the LF group (n=6). (B) While all of the high-fat diet groups
consumed significantly more kcals and gained significantly more weight compared to the LF group, the
FSO group gained significantly less than the SFD and Blend groups.
(Group Mean ± SEM. One-way analysis of variance (A); Two-way analysis of variance, Tukey’s post hoc
(B))
(**p < 0.01, ***p < 0.001, ****p < 0.0001)
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glucose in the Blend group (186.7 ± 13.7 mg/dl), which was not significantly 
different from the HF group, was also significantly higher compared to the LF and 
FSO groups (p = 0.0054 and p = 0.0017, respectively) (Figure 2.2A). Measuring 
the effectiveness of blood glucose clearance, IPGTT analysis revealed impaired 
blood glucose clearance in the SFD and Blend groups compared to LF and FSO 
groups. A two-way ANOVA identified a significant effect of time (F(4,128) = 6.637; 
p < 0.0001) and dietary treatment (F(3,32) = 21.95; p < 0.0001), as well as a time x 
treatment interaction (F(12,128) = 6.637; p < 0.0001) in blood glucose levels 
measured during the IPGTT (Figure 2.2B). Tukey’s post hoc analysis indicated 
significant differences in blood glucose between the HF and LF groups at BL 
(p < 0.05), 15min (p < 0.05), 30min (p < 0.001), 60min (p < 0.0001), and 120min 
(p < 0.05) timepoints. The Blend group had significantly higher blood glucose 
levels compared to the LF group (minutes 30 & 60, p < 0.001; minute 120, 
p < 0.0001). There were no significant differences in blood glucose levels 
between the LF and FSO groups for all timepoints. In contrast to the SFD and 
Blend groups, the FSO group was similar to the LF group and was significantly 
lower than the SFD group at the 30 and 60-minute timepoints (p < 0.01 and p < 
0.0001, respectively) as well as the Blend group at the 30, 60, and 120-minute 
timepoints (p < 0.001, p < 0.0001, and p < 0.001, respectively).  
32 
Locomotor Activity 
There were no differences in the mean total distance traveled (m) between 
the LF, SFD, FSO and Blend groups during open-field behavioral testing 
(25.95 ± 3.186 m, 21.45 ± 4.04 m, 25.04 ± 4.561 m, 24.2 ± 3.148 m, respectively) 
(Figure 2.3A). In addition, when distance travelled was plotted as a function of 
body weight, there were no significant associations observed between distance 
travelled and body weight (Figure 2.3B).  
In contrast, a one-way ANOVA revealed differences in the number of 
center bouts, defined as the number of times the center of the subject entered 
the center of the arena. The mean number of center entries in the LF group were 
significantly greater compared to the SFD group (p = 0.037) (Figure 2.3D). While 
Figure 2.2 Blood Glucose Regulation 
(A) Fasting blood glucose was significantly elevated in groups consuming diets containing saturated
fat (SFD and Blend), but high amounts of fat as flax seed (FSO) did not elevate fasting blood
glucose compared to controls fed LF. (B) Blood glucose clearance measured using IPGTT showed
significantly slower clearance of blood glucose in SFD and Blend groups compared to LF and FSO
groups indicating greater metabolic dysfunction in mice consuming saturated fat. (Group Mean ±
SEM, One-way analysis of variance, Tukey’s post hoc (A); Two-way analysis of variance, Tukey’s
post hoc (B))
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)
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the number of center bouts for the FSO and Blend did not differ from any other 
group, there was a noticeable trend such that the number of center entries 
increased with decreased levels of dietary saturated fat (Mean ± SEM of center 
entries: LF>FSO>Blend>SFD). In addition, analyzing the number of center 
entries as a function of body weight revealed a significant interaction in the LF 
group (F(3,18) = 4.398; p < 0.05). In the LF group, the increased number of center 
entries was correlated with lower body weight r = -0.945; p = 0.004) (Figure 
2.3E).  
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Figure 2.3 Open-field Locomotor Activity 
(A) There were no statistically significant differences in mean total distance traveled between groups.
(B) A linear regression revealed no interaction between distance travelled and body weight or significant
differences between groups. Pooled analysis (not graphically represented) showed no significant
variability in distanced travelled. (C) A visual tracing of locomotor activity in open-field behavioral testing
with green box delineating the center of the arena. (D) In contrast to distance travelled, the SFD group
exhibited increased thigmotaxic tendencies as evidenced by a significantly reduced number of entries
into the center of the arena compared to the LF group (p < 0.05). (E) Moreover, a linear regression
revealed an increased number of center entries was associated with lower body weight in the LF group
(r = - 0.945).
Group Mean ± SEM. One-way analysis of variance (A); One-way analysis of variance, Tukey’s post hoc
(D) (*p < 0.05)
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Discussion 
This study sought to compare metabolic and consummatory phenotypes in 
our model of high saturated or unsaturated fat feeding against previous studies 
that observed obesogenic weight gain, increased food intake, and locomotor 
changes in mice. We observed that metabolic and behavioral changes 
associated with classic obesogenic diets are specifically dependent on the type 
of dietary fats consumed. Similar to other studies, mice with free access to a diet 
high in saturated fat (SFD) consumed significantly more food and also gained 
significantly more weight compared to the LF group. However, we also observed 
that free access to a high-fat diet that contained unsaturated fat from flaxseed oil 
attenuated weight gain compared to a diet high in saturated fat. Moreover, in 
contrast to our SFD, the unsaturated FSO diet preserved normal blood glucose 
clearance and behavior in open-field testing. 
High-fat Diet Promotes Increased Food Intake Leading to 
Obesogenic Weight Gain 
We observed similar food intake in the SFD, FSO and Blend groups 
indicating palatability of all high fat diets were comparable. Interestingly, even 
though all high-fat diet groups gained significantly more weight than the LF 
group, it is important to note that weight gain in the FSO group was significantly 
lower compared to the SFD group. This is consistent with similar observations 
from the Fulton lab and suggests that a diet low in saturated fat but high in 
unsaturated fat attenuates weight gain (Décarie-Spain et al., 2018). However, it 
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is important to note that the beneficial effect of the flaxseed oil substituted for 
saturated fat in the Blend group did not attenuate the excessive weight gain 
observed in the SFD group. This difference may provide insight into the other 
metabolic differences observed between groups described below. But it is also 
important to note that the Blend diet was higher in both saturated fat as well as n-
6 fatty acids compared to the FSO diet. It is possible that the overall amount of 
unsaturated fat was not adequate to counter the effects of the saturated fat. 
Additionally the higher n-6:n-3 fatty acid ratio in the Blend diet may have been a 
confounding factor since there is evidence to suggest that a high n-6:n-3 ratio 
increases risk of obesity (Simopoulos, 2016). 
High-fat Diet Potentiates Metabolic Impairments 
We also sought to confirm that, compared to a low-fat diet, free access to 
a diet high in saturated fat would result in metabolic impairments observed in 
other studies. We observed that the SFD group had significantly elevated fasting 
blood glucose as well as reduced blood glucose clearance compared to the LF 
group. Impaired blood glucose clearance measured by IPGTTs, which is an 
indirect measure of insulin receptor function, is a validated proxy for assessing 
insulin resistance (Ayala et al., 2010). Saturated fat has been shown to promote 
insulin resistance by increasing production of pro-inflammatory cytokines such as 
TNF-α, interleukin (IL)-6, and IL-1β (Rogero and Calder, 2018). In addition, 
saturated fat is also a precursor for several classes of molecules, such as 
ceramides and diacylglycerol, which inhibit insulin signaling pathways (Glass and 
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Olefsky, 2012; Holland et al., 2007). Therefore, the impaired blood glucose 
clearance observed in the SFD group in this study are possibly due in part to the 
pro-inflammatory effects of saturated fat. 
In contrast to saturated fats, unsaturated fats exert a number of anti-
inflammatory effects that are associated with healthy blood glucose regulation 
(Calder, 2015; Lalia and Lanza, 2016). We hypothesized that substituting 
flaxseed oil, which is high in unsaturated fat, would prevent or attenuate the 
effects observed in the SFD group. Interestingly, even though the FSO group 
gain more weight than the LF group, they exhibited a metabolically distinct 
phenotype from the other high fat groups, characterized by reduced weight gain 
and normal fasting blood glucose and IPGTT blood glucose levels. These 
findings support the argument that the FSO group was metabolically similar to 
the LF group, indicating that unsaturated fat has less of an overall metabolic 
impact than saturated fat. 
It is also important to note that mice consuming the Blend diet were 
metabolically similar to those consuming SFD. This suggests that replacing only 
a modest proportion of dietary saturated fat with unsaturated flax seed oil while 
still consuming high amounts of overall total dietary fat is not as effective at 
normalizing metabolic impairments as replacing a majority of dietary saturated fat 
with unsaturated fat. The lack of treatment effect of unsaturated fat in the Blend 
group could be due to several factors. First, the Blend group gained more weight 
than the LF and FSO groups. Since obesity itself promotes a pro-inflammatory 
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state that induces insulin resistance, the excess weight gained by the Blend 
group may have contributed to metabolic dysfunction (McArdle et al., 2013). It is 
also possible that the amount of unsaturated fat in the Blend diet, which was 
lower than the FSO group, was insufficient to overcome the deleterious effects of 
saturated fat. In addition, the Blend diet had a higher n-6:n-3 ratio compared to 
the FSO diet. Increased obesity risk and associated insulin resistance with a high 
fat diet with a high n-6:n-3 ratio versus a diet higher in n:3 has been reported by 
Liu and colleagues (X. Liu et al., 2013). They also observed that a diet high in n-6 
fat was associated with higher inflammatory cytokines compared to the high n-3 
diet. This association between a high n-6:n-3 ratio and inflammation could be 
related to evidence that a high level of n-6 unsaturated fats, which are precursors 
to several classes of pro-inflammatory eicosanoids, may counter the anti-
inflammatory effects of n-3 unsaturated fats (Calder, 2015). 
Anxiogenic Behavior Exhibited with Saturated Fat Diet 
To establish whether the SFD diet in our study produced a behaviorally 
distinct phenotype compared to LF diet observed in previous studies, we 
assessed anxiogenic behaviors using an open field test. An open field test was 
used to evaluate behavior since it provides a rapid assessment of well-validated 
behavioral anxiety in rodents (Seibenhener and Wooten, 2015; Simon et al., 
1994). Previous studies have shown that rodents consuming an obesogenic diet 
high in saturated fats displayed anxiogenic and depressive behaviors evidenced 
by decreased entries into the center of a novel, open-field environment (Cai et 
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al., 2018). These behaviors are associated with anxiety associated with exposure 
to novel environments typified by aversion to large, open areas and a resultant 
display of thigmotaxis (Seibenhener and Wooten, 2015; Simon et al., 1994). In 
our study, the SFD group exhibited increased thigmotaxic tendencies as 
evidenced by a significantly reduced number of entries into the center of the 
arena compared to the LF group. It is important to note that there was no 
difference in the total distance travelled between the LF and SFD groups. This 
suggests that the difference in center bouts observed in the SFD group is not due 
to overall distance travelled but a preference to limit exploration of a novel 
environment to walls in the perimeter. This is consistent with a model of 
anxiogenic behavior reported by the Fulton lab and others who reported a 
significantly decreased number of center entries in an open field test that was 
associated with other markers of anxiety and depression (Cai et al., 2018; 
Décarie-Spain et al., 2018; Sharma and Fulton, 2013). We hypothesized that 
there would be an observed attenuation in anxiogenic behaviors in the 
unsaturated fat diet groups compared to SFD. Interestingly, the FSO group had a 
similar number of center entries compared to the LF group. The FSO group also 
had a greater number of center entries compared to the SFD group. This 
difference was not statistically significant; however, the lack of treatment effect 
for unsaturated fat could be due to a small sample size or the design of the open 
field testing. Similar studies that report significant differences between treatment 
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groups used larger arenas and brightly-lit centers that more clearly elicit 
anxiogenic behaviors in rodents (Seibenhener and Wooten, 2015).  
Conclusion 
Overall, we show that the type of dietary fat, independent of the quantity of 
food consumed impacts body weight. Moreover, the type of dietary fat impacts 
metabolic and behavioral parameters. Mice fed a diet high in saturated fat 
consumed significantly more food and gained significantly more weight compared 
to their LF-fed counterparts. In addition, unlike the LF group, the SFD group 
displayed anxiogenic behaviors in open field tests. These findings verify that our 
SFD model is consistent with the established metabolic syndrome-like phenotype 
observed in previous preclinical models of diet-induced obesity. We also 
observed that an anti-inflammatory diet containing unsaturated fats in the form of 
FSO, in contrast to the SFD diet, attenuated weight gain and preserved blood 
glucose regulation and locomotor behaviors normally disrupted by saturated fat.
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CHAPTER III 
IMPAIRED DOPAMINE NEUROTRANSMISSION IN THE NUCLEUS 
ACCUMBENS OF C57BL/6 MICE IS ASSOCIATED WITH SATURATED BUT 
NOT UNSATURATED FAT INTAKE 
Introduction 
Research related to diet-induced obesity has been traditionally viewed 
through the lens of a homeostatic model of food intake modulated by the 
hypothalamus (Cassidy and Tong, 2017; Coccurello and Maccarrone, 2018). 
However, food intake is also governed by the mesolimbic dopamine signaling 
pathway. Central to this pathway is the nucleus accumbens (NAc), which is the 
limbic-motor interface and primary reward center of the brain (Goto and Grace, 
2008; Salgado and Kaplitt, 2015). The NAc is believed to underlie conditioning 
that links the memory of salient rewards that include both homeostatic and 
hedonic experiences with the context in which they occur and subsequently 
influence the desire and future pursuit of rewarding, salient reinforcers. This is 
significant since the NAc specifically encodes salience of palatable foods and is 
also involved in promoting satiety (Arias-Carrión et al., 2010; Ferrario et al., 
2016; Ferré, 2017; O’Connor et al., 2015).  
There is currently a debate about whether to classify chronic 
overconsumption of food related to obesity as a “food addiction”. However, it is
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well established that highly-palatable foods exert strong effects on the 
dopaminergic reward system. Specifically, there is growing evidence that high fat 
(HF) diets and obesity lead to pathophysiological changes in the dopaminergic 
reward system similar to drug addiction (Di Chiara and Bassareo, 2007; Volkow 
et al., 2013, 2011). These changes are characterized by a hypodopaminergic 
phenotype with dampened dopamine response to rewards. This 
hypodopaminergic phenotype is thought to be initially due in part to reduced 
dopamine transporter (DAT) function that specifically results in delayed 
termination of phasic burst firing, enhanced tonic signaling, and an overall 
increase in synaptic dopamine (Sulzer et al., 2016). Over time, elevated synaptic 
dopamine concentrations lead to a compensatory reduction in post-synaptic 
dopamine D2 receptors and increased consumption of salient rewards (Blum 
et al., 2014; Koob, 2013; Narayanaswami et al., 2013). In addition to changes in 
post-synaptic D2 receptor function, changes in D2 autoreceptors on dopamine 
neurons are also observed with both addiction models and HF diet-induced 
obesity. The effects of HF diets on dopamine autoreceptors is significant since 
these inhibitory dopamine autoreceptors serve a key feedback role (Ford, 2014; 
Robinson et al., 2017). D2 autoreceptors modulate dopamine transmission by 
decreasing dopamine neuron excitability. In addition, dopamine autoreceptors 
regulate dopamine synthesis and decrease the level of dopamine released 
(Beaulieu and Gainetdinov, 2011; Ford, 2014).  
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The underlying mechanisms of HF diet-induced obesity that contribute to 
impaired DAT activity and the adaptive changes in D2 receptor function are not 
well understood. However, insulin may play a central role since it is involved in 
fine-tuning dopamine neurotransmission (Ferrario et al., 2016). Insulin exerts its 
effects by acting on dopamine neurons in the NAc to increase DAT recruitment to 
the plasma membrane (Daws et al., 2011; Doolen and Zahniser, 2001). Insulin 
also functions to fine-tune phasic dopamine bursts which in turn regulate 
postsynaptic dopamine receptor activation and dampen dopamine neuron firing 
in the VTA to reduce food seeking and support meal termination (Daws et al., 
2011; Mebel et al., 2012; Stouffer et al., 2015). Given the important role of insulin 
related to dopamine signaling, there is a strong possibility that an association 
exists between impaired insulin signaling and impaired dopamine 
neurotransmission related to saturated fat and HF diet-induced obesity. This is 
supported by the large body of evidence demonstrating that saturated fat and 
obesity lead to systemic insulin resistance (Chen et al., 2015; Nettleton et al., 
2014; Rehman and Akash, 2016). This is also specifically supported by evidence 
that an obesogenic, high saturated fat diet associated with impaired dopamine 
uptake and insulin resistance was attenuated when insulin signaling at dopamine 
terminals was restored (Fordahl and Jones, 2017). 
While it has been demonstrated that obesity and diets high in saturated fat 
promote peripheral insulin resistance by inducing chronic inflammation, unknown 
is whether inflammation associated with diets high in saturated fat are implicated 
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in impaired dopamine neurotransmission (Chen et al., 2015; Rehman and Akash, 
2016). Additionally, very little is known about the effect of different types of 
dietary fat on dopamine neuron function. However, it is important to address this 
gap since most research to date has only studied dopamine neurotransmission 
using diets that are primarily high in pro-inflammatory saturated fat. In contrast to 
the pro-inflammatory role that saturated fat has in insulin resistance, omega-3 
polyunsaturated fatty acids (PUFA) have an opposing effect that reduce 
inflammation and promotes insulin sensitivity. This is well documented in 
numerous mouse and rat studies where saturated fat-induced insulin resistance 
was attenuated with PUFA supplementation (Kalupahana et al., 2010; Lalia and 
Lanza, 2016; Lionetti et al., 2014; X. Liu et al., 2013). In contrast to saturated fat, 
diets high in unsaturated fats have been reported to promote brain health, 
preserve behavioral responses to dopamine agonists, and improve insulin 
signaling in other regions of the brain, putatively through attenuated inflammation 
(Bazinet and Layé, 2014; Coccurello and Maccarrone, 2018; Trépanier et al., 
2016). These effects have been attributed in part to PUFA’s well-established role 
in reducing pro-inflammatory cytokines. This is supported by a multitude of cell 
and animal studies that demonstrate PUFAs reduce the production of cytokines 
such as TNF-α, IL-6, and IL-1B (Calder, 2015). Collectively, this suggests that 
the type of dietary fat may differentially impact dopamine signaling by mediating 
inflammatory status. While it is not currently known whether or how a diet high in 
unsaturated fat will affect dopamine signaling within the NAc, the 
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anti-inflammatory properties of unsaturated fats suggest that these “healthier” 
fats may preserve normal dopamine signaling.  
Given the divergent roles that saturated and unsaturated fatty acids have 
on inflammation and insulin resistance, as well as the impact that reduced insulin 
signaling has on dopamine neurotransmission, we hypothesized that a diet high 
in saturated fat would induce the production of pro-inflammatory cytokines which 
in turn impair dopamine signaling, but anti-inflammatory unsaturated fats would 
not initiate cytokine production and would therefore preserve dopamine signaling. 
This study specifically examines whether preserving inflammatory balance with a 
diet rich in PUFAs would maintain proper control of the dopamine release and 
uptake mechanisms in the NAc. To test these hypotheses, we measured sub-
second dopamine release and uptake at dopamine terminals in the NAc using 
ex-vivo fast scan cyclic voltammetry (FSCV) in mice fed diets high in saturated or 
PUFA rich flaxseed oil (FSO). We also measured the dopamine terminal 
response to quinpirole, a dopamine D2 receptor agonist, as well as levels of the 
inflammatory cytokine interleukin-6 (IL-6) in the NAc.  
Methods 
Animals and Diet 
Six-week-old male C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) and were housed three per cage, maintained on a 
12 h light/dark cycle with free access to water and either a low-fat control diet 
(LF; 10% kcals from fat; D12450J, Research Diets, n=6) or one of three nutrient 
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matched experimental diets containing 60% kcals from either saturated fat (SFD; 
D12492, Research Diets, n=9), saturated fat combined with flaxseed oil (Blend; 
1:1 ratio of saturated fats to n3 polyunsaturated fats) (n=6) or flaxseed oil alone 
(FSO; n=6). Custom flax diets were similarly nutrient matched to both high and 
low-fat diets, and calorically matched to the high saturated fat diet. Food intake 
was measured on M/W/F by weighing the amount of diet consumed and 
calculating caloric intake based on food disappearance. Total food consumed 
was divided by the number of mice in each cage. Body weights were collected 
upon arrival and weekly thereafter. Mice remained on respective diets for 6 
weeks prior to experimental tests. All experiments followed the University of 
North Carolina at Greensboro Animal Care and Use Committee guidelines.  
Fast Scan Cyclic Voltammetry  
FSCV was used to characterize baseline dopamine release and uptake 
within the NAc core. FSCV is a useful tool to study dopamine neurotransmission 
in the NAc due to its excellent temporal and spatial resolution as well as its 
specificity and sensitivity for dopamine. Importantly, FSCV can measure the 
kinetics of dopamine uptake via the DAT, which is a key commonality observed 
between drug addiction and HF diet-induced obesity models. Since our 
experimental design also included use of the dopamine receptor agonist, 
quinpirole, we were able to characterize dopamine receptor functionality in the 
same locations where dopamine release and uptake are measured to more fully 
characterize overall dopamine neurotransmission in the NAc. 
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All voltammetry experiments were conducted after the 6-week dietary protocol, 
within two weeks after IPGTT using a Latin square design, and began ∼3 h into 
the light cycle. Experimental procedures were executed and modeled as 
previously described (Fordahl and Jones, 2017). Briefly, mice were rendered 
unconscious using 5% isoflurane, decapitated, and the brain swiftly removed. 
The brain was hemisected with one hemisphere submerged in ice cold artificial 
cerebral spinal fluid (aCSF) (NaCl 126 mM, NaHCO3 25 mM, D glucose 11 mM, 
KCl 2.5 mM, CaCl2 2.4 mM, MgCl2 1.2 mM, 452 NaH2PO4 1.2 mM, L-ascorbic 
acid 0.4 mM, pH adjusted to 7.4) for slicing on a compresstome (Precisionary 
Instruments; Greenville, NC), and the other was used to excise NAc tissue for IL-
6 quantification. Next, 300 μm brain slices containing the NAc (from +1.45 to 
+0.74 from bregma) were transferred to the voltammetry chamber and allowed to
equilibrate for 60 min at 31.5 °C while bathed in oxygenated (95% O2/5% CO2) 
aCSF at 100 mL/min. Dopamine was recorded using a triangular waveform 
applied to a glass capillary-pulled carbon-fiber working microelectrode (70-
100 μm length, 7 μm diameter). Briefly, the working electrode penetrated brain 
slices within the NAc core ∼50 μM in depth and a bipolar stimulating electrode 
(Plastics One, Roanoke, VA, 8IMS3033SPCE) was placed on the surface of the 
slice approximately 100-200 μm away from the working electrode. The working 
electrode was maintained at a potential of -0.4 V versus a Ag/AgCl reference 
electrode and subsequently ramped up to +1.2 V and back to -0.4 V at a scan 
rate of 400 V/s every 100ms. Dopamine release was evoked with a single 
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electrical pulse (20Hz, 4 ms pulse width, 350 μA stimulation amplitude) from the 
stimulating electrode every 3 min. Next, dopamine release was evoked using 
5-pulse stimulations (20Hz, 4 ms, 350 μA) to characterize phasic dopamine
release. All recording electrode placements were grouped in the NAc core. 
Dopamine signals were acquired and modeled using Demon Voltammetry 
Software, based on Michaelis−Menten kinetics. Baseline recordings were 
obtained from one to two slices from each animal. To measure dopamine D2 
auto-receptor function at dopamine terminals, quinpirole (Tocris; Minneapolis, 
MN; Cat. No. 1061) was subsequently washed over the slices with cumulative 
half-log applications to obtain a dose response curve (1-100 nM) at the same 
location as baseline collections. Dopamine current was converted to 
concentration by electrode calibration after each experiment using a flow cell, 
adding 3 μM of dopamine in combination with the Demon Analysis Software. 
IL-6 Protein Quantification 
The ventral striatum containing the NAc was rapidly dissected from the 
contralateral brain hemisphere used for voltammetry, and tissue was stored at 
−80 °C until use. An enzyme linked immunosorbent assay (ELISA) kit (Cayman
Chemical, 583371) was used to quantify IL-6 protein content in NAc tissue per 
the manufacturer’s instructions. Briefly, NAc tissue was homogenized in 
phosphate buffered saline (0.02 mol/L pH7.2) containing HALT™ protease 
inhibitor cocktail (ThermoFisher, 1860932) and tissue was further lysed by 
ultrasonication. Homogenates were centrifuged at 5000g for 5 min, and the 
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supernatant was used for BCA protein assay (ThermoScientific, Rockford, IL, 
23225) and the IL-6 ELISA kits. IL-6 content was normalized to tissue protein and 
is reported as pg IL-6/mg protein. 
Statistical Analysis 
Graph Pad Prism v7.04 (La Jolla, CA) was used for all statistical analyses. 
One-way analysis of variance (ANOVA) tests were used to analyze between 
group differences for dopamine release, Vmax, and IL-6 in NAc. Group data are 
presented as means ± SEM and statistical significance was set at P ≤ 0.05. A 
two-way repeated measures ANOVA was used to identify significant differences 
within and between treatment groups for voltammetry dose response curves 
using Tukey’s posthoc analysis to identify significant variations between groups 
at individual data points, when applicable. Pearson’s correlational analysis was 
used to identify relationships between dopamine release and body weight, Vmax 
and body weight, dopamine release and NAc IL-6, and Vmax and NAc IL-6.  
Results 
Effect of Dietary Fat on Dopamine Release and Uptake 
Slice voltammetry was used to characterize differences in dopamine 
release and uptake in the NAc after 6-week exposure to the respective diets. No 
differences in tonic dopamine release were detected between groups 
(1.64 ± 0.72 µM, LF (n = 16); 1.38 ± 0.56 µM, SFD (n = 18); 1.17 ± 0.53 µM, FSO 
(n = 12); 1.36 ± 0.64 µM, Blend (n = 9) (Figure 3.1A). However, a significant 
effect of diet on dopamine uptake was observed (F(3,46) = 4.325; p = 0.001). 
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Tukey’s posthoc analysis revealed the maximal rate of dopamine uptake (Vmax) 
was significantly reduced in the SFD group (1.77 ± 0.34 µM, n = 18) compared to 
the LF (2.21 ± 0.31 µM, n = 10) and FSO (2.18 ± 0.28 µM, n = 12) groups 
(p < 0.05), indicating a reduction in DAT function (Figure 3.1B). No difference 
was observed between the LF and FSO groups suggesting that high amounts of 
dietary unsaturated fat prevented or attenuated impaired DAT function observed 
with a diet high in saturated fat. The Blend group (2.00 ± 0.55 µM, n = 10) was 
not significantly different from the LF, SFD or FSO groups (Figure 3.1B). Overall, 
there was no association between body weight and dopamine release (Figure 
3.1C); however, Pearson’s correlational analysis revealed a significant 
association between weight gain and impaired dopamine clearance in the SFD 
group (r = -0.407, p < 0.05). There was no association between body weight and 
dopamine uptake in the LF, FSO or Blend groups (Figure 3.1D). 
The SFD group (172.9 ± 15.19, n = 9) also had significantly lower phasic 
neuron firing compared to the LF (195.6 ± 19.56, n = 7) and FSO (195.6 ± 25.21, 
n = 5) groups (p < 0.05). There were no other differences between the LF and 
FSO groups. The Blend group (182.8 ± 13.38, n = 4) was not significantly 
different compared to the LF, SFD, or FSO groups (Figure 3.1E). 
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Figure 3.1 Dopamine Release and Uptake. 
Ex-vivo fast scan cyclic voltammetry in slices containing the nucleus accumbens was performed to 
characterize differences in dopamine release and uptake. (A) No differences in dopamine release, 
evoked by a single pulse stimulation, were detected between groups. LF (n = 16); SFD (n = 18); FSO (n 
= 12); Blend (n = 9). (B) Vmax, the maximal rate of dopamine uptake from the synapse was significantly 
reduced in the SFD group (n = 18) compared to the LF (n = 10) and FSO (n = 12) groups (p < 0.05). (C) 
There was no association between body weight and dopamine release evoked by single pulse 
stimulations (D) There was a significant negative association between Vmax and body weight was 
observed in the HF group (r = -0.407, p < 0.05) (E) Multi-pulse (5p20Hz) stimulation was applied to slices 
to elicit dopamine release observed with phasic neurotransmission. The SFD group (n = 9) also had 
significantly lower dopamine release compared to the LF (n = 7) and FSO (n = 5) groups (p < 0.05).  
(Group Mean ± SEM. One-way analysis of variance (A); One-way analysis of variance, Tukey’s post hoc 
(B); Pearson correlation (C, D); One-way analysis of variance, Tukey’s post hoc (E))  
(*p < 0.05) 
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Effect of Dietary Fat on D2 Autoreceptor Function in the NAc 
After collecting baseline parameters, dose response curves for quinpirole 
(a D2/D3 receptor agonist) were collected to characterize differences in D2 
autoreceptor activity. A two-way ANOVA was used to identify differences in 
quinpirole sensitivity, detected by measuring reduced dopamine release with 
increasing quinpirole concentrations. There was a significant main effect of 
quinpirole dose on reduced dopamine release observed within each group 
(F(4, 52) = 177.8; p < 0.0001), but no between group effects were observed when 
Tukey’s multiple comparisons test was applied (Figure 3.2A). However, there 
was a leftward shift in the dose effect of quinpirole in the SFD group compared to 
the LF group indicating a slight increase in sensitivity to quinpirole in the SFD 
group (Figure 3.2B), though not statistically significant (p = 0.1). 
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IL-6 Levels and Dopamine Neurotransmission 
Protein levels of IL-6 were measured in tissue in the ventral striatum 
containing the NAc to assess neuroinflammation. IL-6 in the CNS is upregulated 
during neuroinflammatory events such as CNS infection, injury, and disease. 
Previous studies report significantly higher levels of mRNA expression of 
cytokines including TNF-α, IL-1β, and IL-6 in the CNS with a high-fat diet 
compared to low-fat controls (Wang et al., 2012a). Overexpression of IL-6 has 
also been associated with astrogliosis and microglial activation (Erta et al., 2012). 
There were no significant differences in the IL-6 protein levels between the LF 
(0.0209 ± 0.0034 pg/mg; n = 6), SFD (0.0193 ± 0.0060 pg/mg; n = 6), and FSO 
(0.0212 ± 0.0047 pg/mg; n = 6) groups. In addition, the Blend group (0.0262 ± 
Figure 3.2 Effect of Diet on D2 Autoreceptors 
(A) Dose response curves for the D2/D3 agonist quinpirole were used to identify
changes in dopamine autoreceptor function in NAc slices. There were no significant
differences between groups. (B) However, the SFD group was more sensitive to
quinpirole compared to the LF group as evidenced by the leftward shift in the dose
effect of quinpirole indicating a reduced magnitude of evoked dopamine release.
(Group Mean ± SEM. Two-way analysis of variance, Tukey’s post hoc (A); Two-way
analysis of variance, Tukey’s post hoc (B))
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0.0017 pg/mg; n = 6) was not different from the FSO group; however, the IL-6 
levels in the Blend group were significantly higher compared to the LF and SFD 
groups (p < 0.05) (Figure 3A). When dopamine release was examined as a 
function of IL-6 levels, there were no associations detected (Figure 3B). Similarly, 
no correlations between dopamine uptake and tissue IL-6 levels were observed; 
however, a near significant negative correlation was observed between Vmax 
and IL-6 in the SFD group (r = -0.719, p = 0.053) (Figure 3C), indicating that 
higher levels of IL-6 was associated with reduced dopamine clearance in this 
group. 
 
 
55 
 
 
 
 
 
Discussion 
Effect of Dietary Fat on Dopamine Release and Uptake 
 It is well-established that diets high in saturated fat produce a metabolic 
syndrome-like (MetS) phenotype characterized by obesogenic weight gain and 
impaired blood glucose regulation related to insulin-resistance. Consistent with 
previous studies, we induced a MetS phenotype in our mice with a diet high in 
Figure 3.3 IL-6 Levels Related to Dopamine Neurotransmission 
(A) Dietary effects on IL-6 protein levels in the nucleus accumbens (NAc) revealed 
significantly elevated IL-6 in the Blend group compared to LF and SFD groups. (B) No 
relationship was observed between dopamine release and tissue IL-6; (C) however, a near 
significant negative association between dopamine clearance (Vmax) and IL-6 was 
observed in the SFD group. These data suggest that saturated fat (SFD group) does not 
elevate basal IL-6, but IL-6 selectively impacted dopamine clearance in mice fed saturated 
vs. unsaturated fat.  
(Group Mean ± SEM. One-way analysis of variance (A); Pearson’s correlation (B, C))  
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saturated fat and observed that a diet high in mono- and polyunsaturated fat in 
the form of flaxseed oil prevented metabolic impairments. 
 Previous studies show that saturated fat-induced MetS phenotype is also 
associated with impaired dopamine neurotransmission (Baladi et al., 2011; 
Fordahl et al., 2016; Fordahl and Jones, 2017; Narayanaswami et al., 2013; 
Owens et al., 2012; Serafine and France, 2013; South and Huang, 2008; Speed 
et al., 2011; Williams et al., 2007). We similarly demonstrated that a diet high in 
saturated fat decreased phasic dopamine release and dopamine uptake, 
producing dopamine terminals that were dramatically different than a LF diet; 
however, we report a novel observation that a diet high in polyunsaturated fat 
specifically preserved normal phasic dopamine release and uptake from 
dopamine terminals in the NAc. Our findings build on previous studies which 
reported unsaturated fat, in contrast to saturated fat, prevented dopamine-related 
behavioral changes in locomotion, sensitization to cocaine, as well as 
anxiodepressive behaviors (Décarie-Spain et al., 2018; Serafine et al., 2016).  
Our observation that dampened phasic dopamine release only occurred in the 
SFD group is pertinent since phasic, burst-release of dopamine specifically 
occurs in response to salient stimuli such as high-calorie, highly-palatable food 
(Baik, 2013b, 2013a). This suggests that diets high in saturated fat could 
promote dysregulated feeding by dampening phasic dopamine release and 
subsequently reducing the perceived enjoyment of food thereby leading to 
compensatory intake to achieve the same reward magnitude (Blum et al., 2014; 
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Matikainen‐Ankney and Kravitz, 2018). In addition, D1 receptors preferentially 
respond to phasic burst firing due to their low affinity for dopamine (Beaulieu and 
Gainetdinov, 2011; Burke et al., 2017; Ferrario et al., 2016; Ford, 2014; Scofield 
et al., 2016). Since D1 receptors project to the hypothalamus to promote satiety 
and terminate feeding, reduced phasic burst firing could further promote 
dysregulated feeding (O’Connor et al., 2015). This is supported by findings from 
the Fulton Lab, who reported that a saturated fat diet impaired the D1 
receptor/PKA signaling pathway which is involved with the sensitizing and 
conditioning of response to reward (Hryhorczuk et al., 2016). In contrast, a diet 
high in monounsaturated fat in the form of olive oil preserved normal enzyme 
pathway signaling associated with D1 receptors.  
In addition to the differences in phasic dopamine release, we observed a 
deficit in synaptic dopamine clearance in the SFD group compared to the LF and 
FSO groups. This is consistent with previous reports of in rodents that consume 
a diet high in saturated fat (Fordahl et al., 2016; Fordahl and Jones, 2017). Here 
we report the novel observation that type of dietary fat differentially impacts 
dopamine uptake. Specifically, unsaturated fat in the form of FSO preserved 
normal dopamine uptake and metabolic parameters, despite causing similar 
weight gain. It should also be noted that even though the SFD and FSO groups 
weighed more than the LF group, a negative association between dopamine 
uptake and body weight was only observed in the SFD group. The fact that the 
changes in DAT activity were affected by increased adiposity in the SFD group 
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alone is important to underscore in the context of findings from previous studies 
where similar changes in DAT activity were observed with high-fat, diet-induced 
obesity without consideration of the type of fat (Cone et al., 2013; Fordahl et al., 
2016; Fordahl and Jones, 2017; Narayanaswami et al., 2013). Our results 
suggest that the type of dietary fat is an independent driver of impaired dopamine 
uptake and DAT activity apart from diet-induced obesity.  
One possible reason for the observed differences in DAT activity between 
the SFD group and FSO groups could be associated protein kinase C (PKC) 
activation. PKC, a primary regulator of DAT surface expression, co-localizes with 
DAT and leads to the internalization of DAT (Gabriel et al., 2013; O’Malley et al., 
2010; Vaughan and Foster, 2013). One of the molecules that activates PKC is 
diacylglycerol (DAG) (Melis and Pistis, 2012). Recent research has elucidated 
that different PKC isoforms have varying sensitivity to DAG depending whether 
DAG contains shorter and saturated fatty acids or longer and polyunsaturated 
fatty acids (Kamiya et al., 2016). Moreover, there is evidence that saturated fatty 
acids are preferentially converted to DAG compared to PUFA (Timmers et al., 
2011). Therefore, enhanced PKC activation by DAG driven by saturated fat in our 
SFD group could lead to decreased DAT activity. 
However, in addition the putative direct role of PKC and DAG on DAT 
internalization, extracellular signal regulated kinase (ERK) also regulates DAT 
activity (Vaughan and Foster, 2013). This is highly relevant to our study where 
we observe an insulin-resistant phenotype, as insulin acts on the ERK signaling 
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pathway via PI3K/ Akt kinase signaling to regulate DAT activity (Nash, 2017). 
Indeed, Fordahl and Jones demonstrated that impaired insulin receptor function 
on dopamine neurons associated with an insulin-resistant phenotype causes 
deficits in dopamine uptake. Moreover, saturated fat specifically impairs insulin-
activated regulation of dopamine uptake in the NAc in a PI3K/Akt-dependent 
manner by decreasing dopamine transporter expression on the cell surface and 
reducing dopamine uptake (Patel et al., 2018; Speed et al., 2011).  
 In the current study we also observed that the SFD group exhibited an 
impaired metabolic phenotype that is an indicator of insulin resistance within the 
NAc (Fordahl and Jones, 2017). However, we uniquely demonstrated that FSO 
not only preserved blood glucose regulation but also preserved normal dopamine 
uptake in the NAc. The dramatic difference between the SFD and FSO groups 
may be explained by the well-established evidence that saturated and 
unsaturated fats have opposing effects on normal insulin signaling (Kalupahana 
et al., 2010; Lalia and Lanza, 2016; Lionetti et al., 2014; X. Liu et al., 2013). 
Therefore, while SFD produced an insulin-resistant state that impaired DAT 
activity, the preservation of blood glucose regulation with the FSO diet suggests 
that it preserved overall normal insulin signaling, thereby maintaining normal DAT 
activity. 
Effect of Dietary Fat on D2 Autoreceptor Function in the NAc 
To further characterize dopamine terminal responses to saturated and 
unsaturated fats quinpirole was used to identify changes in dopamine 
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autoreceptor function. Quinpirole is a D2/D3 receptor agonist that reduces the 
magnitude of dopamine release with increasing concentrations (Robinson et al., 
2017). Accordingly, we observed a reduction in dopamine release as quinpirole 
dose increased but did not identify a differential effect of diet on autoreceptor 
activity between dietary treatments. However, the SFD group was more sensitive 
to quinpirole compared to the LF group as evidenced by the leftward shift in the 
dose effect of quinpirole in the SFD group compared to the LF. It is possible that 
increased sensitivity to quinpirole in the SFD group is due to increased dopamine 
autoreceptor activity as a compensatory response to prolonged dopamine 
exposure due to the reduced DAT activity observed in the SFD group. The 
increased D2 autoreceptor sensitivity is potentially an important finding since 
increased sensitivity to D2 autoreceptor agonists has been associated with the 
development of a hypodopaminergic state and subsequent dampened 
dopaminergic responses to salient stimuli (Siciliano et al., 2016, 2015b). 
Additional studies are needed to investigate these effects this since D2 
autoreceptor sensitivity associated with high-fat diet are not well understood. 
However, the results of this study are consistent with previous reports and are 
also similar to findings reported by the France Lab (Fordahl and Jones, 2017). 
The France Lab showed that compared to rats eating standard chow, rats eating 
high fat chow had increased sensitivity to quinpirole-induced discriminative 
stimulus effects and exhibited increased yawning (a behavioral effect of 
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quinpirole) (Baladi et al., 2011; Baladi and France, 2010; Serafine and France, 
2013). 
IL-6 Levels and Dopamine Neurotransmission 
Previous studies observed significantly higher levels of mRNA expression 
of cytokines including TNF-α, IL-1β, and IL-6 in the CNS (hypothalamus) with a 
high-fat diet compared to low-fat controls (Wang et al., 2012b). The Fulton lab 
also reported increased levels of plasma and NAc mRNA levels of TNF-α and IL-
1β with a SFD versus a LF diet or a diet high in monounsaturated olive oil 
(Décarie-Spain et al., 2018). Building on these studies, we specifically assessed 
IL-6 protein expression within the NAc to assess neuroinflammation. While 
measuring cytokine protein expression specifically within the NAc was a strength 
of this study, the NAc affords a small amount of tissue per mouse. This limited 
our analysis of cytokine expression; therefore, future work could include 
measurement of additional cytokines such as TNF-α and IL-1β to more fully 
characterize inflammation.  
There were significantly elevated IL-6 levels in the Blend group compared 
to the LF and SFD groups. This finding was not expected; however, the Blend 
group had higher levels of n-6 PUFA, which have been associated with elevated 
IL-6 levels (Calder, 2015; Patterson et al., 2012). Interestingly, we also observed 
a negative association between dopamine uptake and IL-6 in the SFD group 
suggesting that even though saturated fat did not elevate basal IL-6, it promoted 
an IL-6 sensitivity. The increase in sensitivity to IL-6 associated with changes in 
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dopamine neurochemistry may be a result of microglial activation since SFD has 
been shown to induce inflammation by activating microglia and is specifically 
associated with abnormal and prolonged activation of the IL-6 target, STAT3 
(Erta et al., 2012; Lee et al., 2003; Vigneswara et al., 2012; Wang et al., 2013). 
This is significant since cytokines such as IL-6 that are released by microglia are 
known to cause neuronal insulin resistance (Ferreira et al., 2014). When insulin 
is unable to exert effects on dopamine neurons we observe a resultant decrease 
in dopamine uptake in the NAc. 
While we did not observe a significant effect of dietary fat on IL-6 protein 
level expression, neurons, astrocytes, microglia and endothelial cells in the CNS 
only synthesize modest basal levels of IL-6 (Erta et al., 2012). Reactive IL-6 
release from these cell types may only occur when challenged by damaging 
stimuli such as stroke, neurodegeneration, or agents associated with infection 
such as bacterial lipopolysaccharide (LPS) (Erta et al., 2012). Studies that 
induced a mounted inflammatory response with oxidative stress or application of 
LPS reported elevated levels of cytokines such as IL-6, TNF-α and IL-1β that 
were associated with changes in dopamine neuron function (Vumma et al., 2017; 
Wang et al., 2018). It is possible that the low levels of chronic inflammation, as 
observed with high amounts of saturated fat, may prime these immune response 
cells for an expedited or enhanced response to such stimuli. Enhanced reactivity 
of these immune cells may contribute to reports of poor prognosis in obese 
individuals that suffer from neurological injuries (Bas and Ozdemir, 2017; Cai, 
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2013). Since IL-6 in the CNS is upregulated during neuroinflammatory events 
such as LPS-induced injury, future studies could use LPS to initiate a 
neuroinflammatory response to better characterize diet-related differences.  
Conclusion  
Overall, this study demonstrated that different types of dietary fat have 
substantially different effects on dopamine terminal regulation. A diet high in 
saturated fat resulted in dampened phasic dopamine release and impaired 
dopamine uptake, all of which were prevented by a diet high in unsaturated fat. 
These differences may be associated with differential effects of fatty acids on 
signaling pathways such as DAG-PKC activation. However, given the known 
effects of insulin on dopamine neurotransmission, it is striking that the FSO diet 
also preserved blood glucose regulation, which was drastically impaired by high 
saturated fat. Evidence from previous studies demonstrating the effects of insulin 
on DAT activity in conjunction with the known effects of dietary fats on insulin 
sensitivity strongly suggest that the observed difference in DAT activity between 
the SFD and FSO groups is associated with the insulin sensitivity of dopamine 
neurons (Fordahl et al., 2016; Jones et al., 2017; Patel et al., 2018). The 
observed decrease in phasic dopamine release in the SFD group might also be 
attributed to impaired insulin sensitivity since the overall effect of post-prandial 
insulin release leads to reduced dopamine signaling (Liu et al., 2016; Mebel et 
al., 2012). An insulin-resistant state may cause altered dopamine signaling in the 
long term when chronically prolonged dopamine signaling in the NAc leads to 
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counter-regulatory neuroplastic changes including a hypodopaminergic, 
dampened phasic dopamine response. Our findings indicate that type of fat 
differentially impacts dopamine terminal regulation, which we show is related to 
the metabolic status of the mice. The impact of dietary fat and altered 
metabolism on neuroinflammation may contribute to this process, but further 
inquiry is necessary to characterize this relationship. The impact of dietary fat on 
dopamine neurotransmission is particularly relevant to neurological control of 
feeding, since dopamine signaling in the NAc helps initiate satiety (O’Connor et 
al., 2015). In conclusion, our findings suggest that a diet high in unsaturated fat, 
in the form of flaxseed oil, may preserve dopamine signaling in the NAc, and 
presumably improve satiety mechanisms compared with saturated fat.
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CHAPTER IV 
EPILOGUE 
There is a growing body of evidence that implicates diets high in saturated 
fat with increased risk for the development of metabolic syndrome in humans 
(Chen et al., 2015; Nettleton et al., 2014; Rehman and Akash, 2016). Similarly, 
rodent studies investigating the effects of dietary fat report the development of 
metabolic syndrome-like phenotypes characterized by obesogenic weight gain, 
insulin resistance, and chronic inflammation after consuming high amounts of 
saturated fat (Décarie-Spain et al., 2018; Jais and Brüning, 2017; Rogero and 
Calder, 2018). 
Emerging evidence has revealed that obesity and diets high in saturated 
fat are linked with pathophysiological changes in the dopaminergic reward 
system that disrupt satiety signals governing homeostatic food intake. Diets high 
in saturated fat are also implicated in the development of a metabolic syndrome-
like phenotype characterized by obesogenic weight gain, insulin resistance, and 
chronic inflammation (Chen et al., 2015; Décarie-Spain et al., 2018; Jais and 
Brüning, 2017; Nettleton et al., 2014; Rehman and Akash, 2016; Rogero and 
Calder, 2018). While there is evidence that anti-inflammatory unsaturated fats 
promote healthier metabolic profiles and brain health, little is known about the 
effects of diets high in unsaturated fat on dopamine neurotransmission which
 
 
66 
 
plays a role in feeding and satiety circuits (Bazinet and Layé, 2014; Calder, 2015; 
Coccurello and Maccarrone, 2018; Trépanier et al., 2016).  
The purpose of this project was to determine whether a diet high in 
unsaturated fat, in contrast to saturated fat, would prevent the development of 
metabolic disorders and preserve normal dopamine function. Mice fed a diet high 
in saturated fat (SFD) consumed significantly more food and gained significantly 
more weight compared to their low fat (LF)-fed counterparts. In addition, unlike 
the LF group, the SFD group displayed anxiogenic locomotor behaviors in open 
field tests. Interestingly, the group fed a flaxseed oil (FSO) diet consumed the 
same amount of food as the SFD group; however, the FSO diet attenuated 
weight gain and preserved normal blood glucose regulation and locomotor 
behaviors. Significantly, the SFD group also exhibited dampened phasic 
dopamine release, impaired dopamine uptake and increased sensitivity to 
quinpirole, all of which was prevented with the FSO diet. There was also a 
negative association between dopamine uptake and IL-6 in the SFD group 
suggesting IL-6 selectively corresponded with reduced dopamine uptake in mice 
fed saturated versus unsaturated fat. Collectively, we demonstrated that different 
types of dietary fat have substantially different effects on metabolic phenotype 
and dopamine terminal regulation. In contrast to a diet high in saturated fat, a diet 
high in unsaturated fat preserved both normal metabolic and behavioral 
parameters as well as dopamine signaling in the NAc. 
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We demonstrated that different types of dietary fats have dramatically 
different effects on dopamine release and uptake. Previous studies have also 
shown that saturated fat promotes inflammation while diets high in unsaturated 
fats promote brain health, preserve behavioral responses to dopamine agonists, 
and improve insulin signaling putatively though attenuated inflammation. 
However, additional research is required to understand the role of dietary fats on 
inflammation associated with dopamine neuron function. IL-6 levels collected in 
this study were not elevated; however, collection of additional key inflammatory 
cytokines associated with insulin resistance, such as TNF-α, and IL-1β, would 
more fully characterize inflammation in the NAc. Moreover, use of 
lipopolysaccharide to initiate a heightened neuroinflammatory response could 
better characterize diet-related differences in production of cytokines. Direct 
measurement of microglia activation within the NAc could also demonstrate the 
role of microglia and inflammation on dopamine release and uptake.  
It is also important to underscore that in contrast to unsaturated fat, the 
inflammation induced by diets high in saturated fat also causes insulin 
resistance. Indeed, we demonstrated that the FSO diet preserved glucose 
regulation while SFD impaired glucose regulation. We did not observe an 
association between peripheral blood glucose regulation and dopamine 
regulation, however we did not directly measure the effect of insulin in the NAc. It 
is therefore warranted to more fully investigate the effects of FSO versus SFD 
through methods such as the direct application of insulin in the NAc since insulin 
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fine tunes dopamine neurotransmission in the NAc to trigger satiety circuits and 
also dampens dopamine neuron firing to reduce food seeking and support meal 
termination (Ferrario et al., 2016). In addition, it would be important to study the 
effects of insulin in the NAc in an inflammatory state through experimental 
methods such as the application of lipopolysaccharide or direct exposure to 
exogenous cytokines (Bas and Ozdemir, 2017; Cai et al., 2018; Erta et al., 2012; 
Vumma et al., 2017; Wang et al., 2018). This would discern whether 
inflammation alone or inflammation-induced insulin resistance in the NAc is 
implicated in decreased dopamine release and uptake.  
It is critical to understand how diets high in saturated fat cause 
dysregulated dopamine signaling in the NAc since it would provide evidence to 
link pathological behaviors of diet-induced obesity such as excessive/compulsive 
food seeking and consumption that exceed metabolic needs. Additionally, 
identifying whether inflammation causes similar deficits in NAc dopamine 
neurotransmission as SFD-induced insulin resistance will help us develop anti-
inflammatory therapeutic strategies, diet or otherwise, that restore dopamine 
signaling, promote satiety, and potentially treat diet-induced obesity.
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